Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Org Chem ; 89(10): 6651-6663, 2024 May 17.
Article in English | MEDLINE | ID: mdl-38663026

ABSTRACT

This article outlines the process development leading to the manufacture of 800 g of BMS-986189, a macrocyclic peptide active pharmaceutical ingredient. Multiple N-methylated unnatural amino acids posed challenges to manufacturing due to the lability of the peptide to cleavage during global side chain deprotection and precipitation steps. These issues were exacerbated upon scale-up, resulting in severe yield loss and necessitating careful impurity identification, understanding the root cause of impurity formation, and process optimization to deliver a scalable synthesis. A systematic study of macrocyclization with its dependence on concentration and pH is presented. In addition, a side chain protected peptide synthesis is discussed where the macrocyclic protected peptide is extremely labile to hydrolysis. A computational study explains the root cause of the increased lability of macrocyclic peptide over linear peptide to hydrolysis. A process solution involving the use of labile protecting groups is discussed. Overall, the article highlights the advancements achieved to enable scalable synthesis of an unusually labile macrocyclic peptide by solid-phase peptide synthesis. The sustainability metric indicates the final preparative chromatography drives a significant fraction of a high process mass intensity (PMI).


Subject(s)
Macrocyclic Compounds , Macrocyclic Compounds/chemistry , Macrocyclic Compounds/chemical synthesis , Peptides, Cyclic/chemistry , Peptides, Cyclic/chemical synthesis , B7-H1 Antigen/antagonists & inhibitors , B7-H1 Antigen/chemistry , Peptides/chemistry , Peptides/chemical synthesis , Solid-Phase Synthesis Techniques , Molecular Structure
2.
AAPS PharmSciTech ; 20(5): 184, 2019 May 06.
Article in English | MEDLINE | ID: mdl-31062111

ABSTRACT

Proper risk analysis needs to be in place to understand the susceptibility of protein to unfold and aggregate in the presence of interfacial and/or shear stress. Certain techniques, such as agitation/shaking studies, have been traditionally used to understand the impact of these stresses on the protein physical stability. However, the stresses applied in these systems are convoluted, making it difficult to define the control strategy (i.e., adjustment in process parameters to reduce foaming/bubble formation, change pump type). We have developed two small-scale tools that allow for the isolation of interfacial and shear stress, respectively. These systems, in combination with computational fluid dynamics and numerical approximations, help simulate the normal operating ranges as well as the proven acceptable ranges for different unit operations such as tangential flow filtration (TFF), mixing, and filling.


Subject(s)
Biological Products/chemistry , Chemistry, Pharmaceutical/instrumentation , Drug Stability , Image Processing, Computer-Assisted , Particle Size , Protein Stability , Proteins/chemistry , Stress, Mechanical
SELECTION OF CITATIONS
SEARCH DETAIL
...